Ken Kraemer

Ken Kraemer discusses xeroderman pigmentosum with various media outlets

Dec 19, 2018

Kenneth Kraemer, M.D., Senior Investigator in the Laboratory of Cancer Biology and Genetics, has been featured by several media outlets discussing xeroderma pigmentosum (XP), a very rare skin disorder that makes a person highly sensitive to sunlight and prone to developing skin cancers. Dr. Kraemer provided some background on the dangers of living with XP for a Russia Today documentary and discussed the use of three large databases to estimate the prevalence of defective DNA repair variants in the United States with MedicalResearch.com. Read more...

Valery Bliskovsky, Ph.D.

In Memoriam: Valery Bliskovsky, Ph.D.

Nov 28, 2018

CCR mourns the loss of Valery Bliskovsky, Ph.D., a pioneer in genomics technologies and Staff Scientist in the CCR Genomics Core, who died on November 13. Dr. Bliskovsky began his NIH career in 1994 as a visiting fellow in the Laboratory of Biological Chemistry at the NCI. In 1996, he moved to the Laboratory of Genetics under Beverly Mock, Ph.D., which later became a part of the Laboratory of Cancer Biology and Genetics (LCBG). In 2012, Dr. Bliskovsky joined the CCR Genomics Core to implement advanced genomic technologies, such as the first Illumina Next-Generation Sequencing platform and digital droplet ddPCR. His deep knowledge about emerging genomic technologies and his enthusiasm to enable CCR investigators to apply these to their research made him invaluable to the CCR and the wider NIH scientific community. As a collaborator remarked: “Val’s presence filled a room. He had a big personality, a love for life and a huge heart.” Read more...

Steven Rosenberg

Steven Rosenberg featured in The Wall Street Journal

Nov 14, 2018

Steve Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, was featured in an article in The Wall Street Journal discussing immunotherapy. The article primarily focuses on the history and future of immunotherapy and discusses Dr. Rosenberg’s role in the discovery and pursuit of immunotherapy as a cancer treatment.   Read more...

Vanja Lazarevic

NICHD press release features new paper from CCR investigator Vanja Lazarevic

Nov 2, 2018

The National Institute of Child Health and Human Development recently issued a press release on a new collaborative paper with Vanja Lazarevic, Ph.D., Investigator in the Experimental Immunology Branch, and others from institutes across NIH. The paper, “Regulation of myelin structure and conduction velocity by perinodal astrocytes,” suggests that astrocytes play an important role in how the brain processes information.  Read more...

Christopher Kanakry, M.D.

Christopher Kanakry appointed as an NIH Lasker Scholar Tenure Track Investigator

Oct 26, 2018

Christopher Kanakry, M.D., has been appointed as an NIH Lasker Scholar Tenure Track Investigator in the Experimental Transplantation and Immunology Branch. Dr. Kanakry pursues basic, translational, and clinical research related to allogeneic hematopoietic cell transplantation. His work largely centers on better understanding and developing the use of post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. Read more...

Jack Shern, M.D.

Jack Shern appointed as an NIH Lasker Scholar Tenure Track Investigator

Oct 26, 2018

Jack Shern, M.D., has been appointed as an NIH Lasker Scholar Tenure Track Investigator in the Pediatric Oncology Branch. Dr. Shern previously served as an Assistant Clinical Investigator in CCR's Clinical Investigator Development Program. Dr. Shern's research focuses on defining and developing precision therapies targeting the genetic mutations that drive tumorigenesis. Read more...

Chongyi Chen, Ph.D.

Chongyi Chen appointed as Stadtman Tenure Track Investigator

Oct 5, 2018

Chongyi Chen, Ph.D., has joined the Laboratory of  Biochemistry and Molecular Biology as a Stadtman Tenure Track Investigator. Dr. Chen joins us from Harvard University. His research focuses on the interface between DNA sequence, chromosome organization and gene expression in both bulk samples and single cells from a genome-wide perspective. Read more...

Andres Lebensohn, Ph.D.

Andres Lebensohn appointed as Stadtman Tenure Track Investigator

Oct 5, 2018

Andres Lebensohn, Ph.D., has joined the Laboratory of Cellular and Molecular Biology as a Stadtman Tenure Track Investigator. Dr. Lebensohn joins us from Stanford University. His research focuses on understanding how signaling pathways are used, reused and repurposed to drive the myriad different cellular processes that give rise to tissues and organs during embryonic development and maintain them in adult life.  Read more...

Kenneth Kraemer

Kenneth Kraemer receives 2018 Environmental Mutagenesis and Genomics Society Award

Sep 25, 2018

Kenneth Kraemer, M.D., Senior Investigator in the Laboratory of Cancer Biology and Genetics, has received the 2018 Environmental Mutagenesis and Genomics Society (EMGS) Award. The annual award is given in recognition of outstanding research contributions in environmental mutagenisis. Dr. Kraemer is presenting the plenary lecture at the 2018 EMGS Annual Meeting on September 25, 2018, in San Antonio, Texas. Read more...

Barry O'Keefe

Barry O’Keefe featured in ShareAmerica article

Sep 19, 2018

Barry O’Keefe, Ph.D., Acting Chief of the Molecular Targets Program and Chief of the Natural Products Branch of the Division of Cancer Treatment and Diagnosis, was featured in a ShareAmerica article. Dr. O’Keefe, along with an international team of scientists, worked together to figure out how to combine three HIV-blocking proteins into ordinary seeds of rice that could be turned into an ointment to prevent HIV infections. In the article, Dr. O’Keefe discusses natural products, particularly a powerful protein in marine red algae from New Zealand that he first showed in 2005 could work to kill HIV-related microbes. Read more...

Pages